Researchers in Australia have recently published a meta-analysis of research looking at the complex world of measuring and quantifying cannabis impairment.
A Swiss/German group published a method that can be used to measure the quantity and viability of Cannabis sativa pollen. This method could be useful to companies with an in-house breeding program to be first to market with the latest strain.
Cannabis terpene compounds have recently been the subject of studies regarding their potential for pain management. The following is a summary of some of the promising results, as presented in a recent review circulated on PubMed.
Université de Moncton is looking to hire a Research Chair on therapeutic cannabis. The successful candidate will work at the New Brunswick Center for Precision Medicine, focusing on the effects and specificity of cannabinoids in the treatment of diseases and pathophysiological conditions.